Takara Bio (TKBIF) Stock Price, News & Analysis

Company Overview

Takara Bio Inc., a subsidiary of Takara Holdings Inc., is a global provider of innovative biotechnological products and services. Headquartered in Kusatsu, Shiga, Japan, the company specializes in developing and marketing reagents and instruments for molecular biology, cell biology and genomic research. With roots tracing back to Takara Shuzo Co., Ltd.’s life sciences division, Takara Bio has leveraged decades of experience to support scientific discovery and biopharmaceutical development.

Takara Bio’s core offerings include polymerase chain reaction (PCR) enzymes and kits, DNA and RNA purification systems, cloning and gene expression reagents, and advanced genome editing tools such as CRISPR/Cas systems. The company also provides viral vector technologies for gene therapy research, custom contract development and manufacturing services, and immunoassay platforms. These products and services serve a diverse customer base of academic institutions, pharmaceutical companies and biotechnology firms, facilitating applications from basic research to preclinical and clinical studies.

Operating through a network of subsidiaries and distribution partners across North America, Europe and the Asia-Pacific region, Takara Bio supports researchers and developers on a global scale. The company continually invests in next-generation technologies and strategic collaborations to expand its product portfolio, enhance research workflows and advance precision medicine and cellular therapies. With a focus on quality, reliability and scientific innovation, Takara Bio aims to accelerate breakthroughs in life sciences and biopharmaceutical research.

Key Stats

• Today's Range: $7.30 to $7.30
• 50-Day Range: $7.30 to $7.30
• 52-Week Range: $5.00 to $7.30
• Volume: N/A
• Average Volume: 100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 6/24/2026
• Next Earnings (Estimated): 8/07/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:TKBIF
• CIK: N/A
• Web: www.takara-bio.com
• Phone: 81 77 565 6920
• Fax: N/A
• Employees: 1,539
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A